Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?-Reference-Cited by-同舟云学术

Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?

Published:2015-10-13 Issue:11 Volume:16 Page:1165-1171
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Pirozzi Luisella,Sountoulides Petros,Castellan Pietro,Presicce Fabrizio,Lombardo Riccardo,Romero Marilena,Nunzio Cosimo,Tubaro Andrea,Schips Luigi,Cindolo Luca

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of vardenafil and tamsulosin in treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A randomised clinical trial;Journal of Clinical Urology;2024-02-12

2. Ethanol Extracts of Cornus alba Improve Benign Prostatic Hyperplasia by Inhibiting Prostate Cell Proliferation through Modulating 5 Alpha-Reductase/Androgen Receptor Axis-Mediated Signaling;The World Journal of Men's Health;2024

3. A systematic review and meta-analysis of efficacy and safety comparing greenlight laser vaporization with transurethral resection of the prostate for benign prostatic hyperplasia with prostate volume less than 80 ml;Lasers in Medical Science;2023-06-08

4. A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov;Medicina;2023-06-07

5. Photothermal therapeutic potency of plasmonic silver nanoparticles for apoptosis and anti-angiogenesis in testosterone induced benign prostate hyperplasia in rats;Life Sciences;2022-02